Clorox Reports Q1 Fiscal Year 2017 Results, Including Strong Sales Growth; Updates Fiscal Year Tax-Rate Assumptions for EPS Outlook

Go back to Clorox Reports Q1 Fiscal Year 2017 Results, Including Strong Sales Growth; Updates Fiscal Year Tax-Rate Assumptions for EPS Outlook

UBS Cuts Price Target on Clorox (CLX) to $111 Following 1Q EPS Miss

November 3, 2016 8:50 AM EDT

UBS maintained a Sell rating on Clorox (NYSE: CLX), and cut the price target to $111.00 (from $118.00), following the company's 1Q earnings report. CLX missed EPS, reporting $1.36 compared to consensus of $1.42. CLX lowered FY17 EPS guidance to $5.23-$5.43 (from $5.38-$5.58 prior).

Analyst Stephen Powers... More

Clorox (CLX) Misses Q1 EPS by 6c; Reaffirms Guidance

November 2, 2016 6:33 AM EDT

Clorox (NYSE: CLX) reported Q1 EPS of $1.36, $0.06 worse than the analyst estimate of $1.42. Revenue for the quarter came in at $1.44 billion versus the consensus estimate of $1.43 billion.

GUIDANCE:

Clorox maintains sees FY2017 excluding ASU EPS of $5.13-$5.28,... More